SCA
BIIB icon

Strategic Capital Alternatives’s Biogen BIIB Stock Holding History

Strategic Capital Alternatives’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$2.15M Buy
7,374
+6,128
+492% +$2.02M 0.46% 69
2015
Q2 		$504K Buy
1,246
+1,111
+823% +$446K 0.12% 129
2015
Q1 		$57K Buy
+135
New +$53.2K 0.01% 231
2014
Q4 		– Sell
-109
Closed -$36K – 126
2014
Q3 		$36K Buy
+109
New +$35.9K 0.01% 263

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Strategic Capital Alternatives's BIIB Position: Q3 2015 in Review

Strategic Capital Alternatives increased its Biogen (BIIB) stake by 492% in Q3 2015, buying an estimated $2.02M and bringing the position to 7,374 shares worth $2.15M. The position accounts for 0.46% of the portfolio, ranked #69.

Strategic Capital Alternatives first reported a position in BIIB in Q3 2014 and has held it in 4 quarters since. 924 funds tracked by Wall St. Rank hold BIIB as of Q3 2015.

  • Strategic Capital Alternatives held 7,374 shares of Biogen worth $2.15M as of Q3 2015.
  • Strategic Capital Alternatives bought 6,128 Biogen shares in Q3 2015, an estimated $2.02M.
  • Biogen made up 0.46% of Strategic Capital Alternatives's portfolio in Q3 2015, its #69 holding.
  • Strategic Capital Alternatives first reported a position in Biogen in Q3 2014 and has held it in 4 quarters since.
  • 924 funds tracked by Wall St. Rank held Biogen as of Q3 2015.

Based on Strategic Capital Alternatives's 13F filing for Q3 2015, filed 16 Nov 2015.